Search For "serum institute"
Will have to wait for final words in scientific journal: CSIR chief on Cov
Updated : 5 years, 6 months ago IST
New Delhi [India], November 25 (ANI): A day after Serum Institute of India (SII) Chief Executive Officer Adar Poonawalla asserted that its "soon to be widely available COVID-19 vaccine will offer protection up to 90 per cent in one type of dosage regime", Council of Scientific and Industrial
Read More
Serum Institute of India CEO expresses delight at Covishield vaccine effic
Updated : 5 years, 6 months ago IST
New Delhi [India], November 23 (ANI): Serum Institute of India (SII), CEO, Adar Poonawalla on Monday said that he is delighted to hear that Covidshield, soon to be widely available COVID-19 vaccine, will offer protection up to 90 per cent in one dosage regime and 62 per cent in another.
Read More
COVISHIELD completes enrolment of Phase III clinical trials under ICMR, SI
Updated : 5 years, 6 months ago IST
New Delhi [India], November 12 (ANI): The Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) have announced the completion of enrolment of phase 3 clinical trials for COVISHIELD in India.
Read More
After Serum Institute tweet, Union Health Ministry says its disagrees with
Updated : 5 years, 7 months ago IST
New Delhi [India], September 29 (ANI): Following a tweet by the Serum Institute of India, the Union Health Ministry on Tuesday said it disagrees with the mathematics which asked the government whether it has Rs 80,000 crore to buy and distribute COVID-19 vaccine to everyone in India.
Read More
Serum Institute of India to produce additional 100 million COVID-19 vaccin
Updated : 5 years, 7 months ago IST
Pune (Maharashtra) [India], September 29 (ANI): Serum Institute of India (SII) will produce up to an additional 100 million COVID-19 vaccine doses for India and low and middle-income countries (LMICs) in 2021.
Read More
Serum Institute all set to begin phase 3 trials of Covid-19 vaccine
Updated : 5 years, 8 months ago IST
Pune (Maharashtra) [India], September 19 (ANI): Serum Institute of India (SII) is all set to begin phase three trials of the Covishield Vaccine developed by AstraZeneca and Oxford University at Sassoon General Hospital in Pune, the hospital administration said on Saturday.
Read More
DCGI gives nod to Serum Institute to restart phase 2,3 trials for COVID-19
Updated : 5 years, 8 months ago IST
New Delhi [India], September 16 (ANI): The Drugs Controller General of India (DCGI) has allowed Serum Institute of India (SII) to restart its phase two and three clinical trials for COVID-19 vaccine after the pharma major submitted the recommendations of the Data Safety Monitoring Board (DSM
Read More
Serum Institute to resume COVID-19 vaccine trials in India after DCGI nod
Updated : 5 years, 8 months ago IST
New Delhi [India], September 12 (ANI): Hours after clinical trials for AstraZeneca and Oxford University coronavirus vaccine resumed on Saturday in the UK, pharma major Serum Institute of India (SII) said it will resume the trials in India once Drugs Controller General of India (DCGI) gives
Read More
DCGI directs Serum Institute to suspend any new recruitment in phase 2, 3
Updated : 5 years, 8 months ago IST
New Delhi [India], September 12 (ANI): The Drugs Controller General of India (DCGI) Dr VG Somani on Friday ordered the pharma giant Serum Institute of India (SII) to suspend any new recruitment in phase 2 and 3 clinical trials for COVID-19 vaccine till further orders.
Read More
Serum Institute says will adhere to DCGI instructions after show cause ove
Updated : 5 years, 8 months ago IST
New Delhi [India], September 9 (ANI): Hours after the Drugs Controller General of India (DCGI) issued a show-cause notice Serum Institute of India (SII) asking for an explanation as to why the ongoing clinical trial of Covishield vaccine candidate has not been suspended till doubts about
Read More
DCGI sends show cause notice to Serum Institute for not pausing trial of
Updated : 5 years, 8 months ago IST
New Delhi [India], September 9 (ANI): The Drugs Regulator General of India (DCGI) has issued a show-cause notice to pharma giant Serum Institute of India (SII) asking for an explanation as to why the ongoing clinical trial of Covishield vaccine candidate has not been suspended till doubts
Read More
Oxford COVID-19 vaccine trials not paused in India, clarifies Serum Instit
Updated : 5 years, 8 months ago IST
New Delhi [India], September 9 (ANI): After AstraZeneca suspended the trials of COVID-19 vaccine in the UK, Indian pharmaceutical giant Serum Institue of India (SII) on Wednesday clarified that testing of the possible vaccine candidate in India is ongoing and has not faced any issue so far.
Read More